KYTX Stock Analysis: Buy, Sell, or Hold?

KYTX - Kyverna Therapeutics, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$8.43
0.13 (1.57%) ▲
5d: +3.44%
30d: -5.28%
90d: +6.84%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 11, 2026

Get Alerted When KYTX Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: KYTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: KYTX is currently trading at $8.43, which is considered fair relative to its 30-day fair value range of $7.81 to $8.70.

Technical Outlook: Technically, KYTX is showing sideways momentum. The price is approaching resistance at $8.57. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: KYTX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Implied Volatility is high (94th percentile), indicating expensive options premiums. This environment often favors selling options or covered calls to generate income. Wall Street analysts see significant upside, with an average price target of $30.40 (+260.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $7.81 - $8.70
Company Quality Score 53/100 (HOLD)
Options IV Signal 94th percentile (EVENT RISK)
Volume Confirmation HIGH
Confidence Score 68.8%

All Signals

  • NEUTRAL: Price in fair range
  • BEARISH: Options expensive (IV 94th percentile)
  • BULLISH: Strong technical setup (60/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 260.6% below Wall St target ($30.40)

Trading Range Analysis

30-Day Trading Range $7.81 - $8.70
Current vs Trading Range FAIR
Expected Move (7 Days) ±$2.08 (24.7%)

Support & Resistance Levels

Support Level $7.60
Resistance Level $8.57
Current Trend Sideways
Technical data as of Jun 23, 2026

Fundamental Context

Forward P/E (Next Year Est.) -2.85
Wall Street Target $30.40 (+260.6%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 8:11 PM ET
Data refreshes hourly during market hours. Next update: 9:11 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for KYTX.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NTLA
Intellia Therapeutics Inc
STRONG BUY
29 analysts
$27 56 HOLD
ONC
BeiGene, Ltd.
STRONG BUY
24 analysts
$412 57 HOLD
ARGX
argenx NV ADR
STRONG BUY
22 analysts
$1022 67 BUY
INSM
Insmed Inc
STRONG BUY
21 analysts
$197 61 BUY
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD

More Analysis for KYTX

KYTX Technical Chart KYTX Price Prediction KYTX Earnings Date KYTX Investment Advisor KYTX Fair Price Analyzer KYTX Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals